SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 184.82-2.0%Dec 5 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (16353)3/4/1998 4:00:00 PM
From: Andrew H  Read Replies (3) of 32384
 
Henry is a P3 a sine qua non for FDA approval? If so, how could LGND file an application for oral Pannretin based on two P2 trials? Or is it the case that you just need a certain amount of data tracking results under certain conditions?

As for LGND's website, they will be hard pressed to provide the info that yours does!

Well, not much to do as LGND marches inexorably higher.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext